Meet with us atACS Fall 2024

Join Daniel Barr to hear more about how deep learning imputation prioritises the most relevant data, accounts for uncertainty, and guides experiment selection to bring additional value to small molecule discovery.

Optibrium appoints Ian Smith as Chief Technology Officer

New role will lead technology development as the Company continues to scale team and global business operations. Appointment of former Merck, Sharp and Dohme (MSD) Director of R&D Analytics supports continued innovation of Optibrium’s AI drug discovery software.